The global diabetes care devices market was valued at around $13 billion in 2017. Read More: https://www.thebusinessresearchcompany.com/report/diabetes-care-devices-global-market-report-2018

1. Diabetes Care Devices Global
Market Report 2018
Including: Blood Glucose Test Strips; Insulin Pens; Insulin Syringes; Insulin Pumps and injectors; Lancing
Devices; Continuous Glucose Monitoring Devices; Blood Glucose Meters
Covering: Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company
Feb 2018

2. Reasons to Purchase
• Outperform competitors using accurate up to date demand-side dynamics
information.
• Identify growth segments for investment.
• Facilitate decision making on the basis of historic and forecast data and the
drivers and restraints on the market.
• Create regional and country strategies on the basis of local data and analysis.
• Stay abreast of the latest customer and market research findings
• Benchmark performance against key competitors.
• Develop strategies based on likely future developments.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high
quality data and analysis
• Gain a global perspective on the development of the market.
• Report will be updated with the latest data and delivered to you within 3-5
working days of order.
Markets Covered: Blood Glucose Test Strips; Insulin Pens; Insulin Syringes; Insulin Pumps
and injectors; Lancing Devices; Continuous Glucose Monitoring Devices; Blood Glucose
Meters
Companies Mentioned: Roche, Medtronic, J&J, Abbott, Becton, Dickinson and Company
Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and
Australia.
Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America,
Middle East And Africa.
Time series: Five years historic and forecast.
Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita,
Diabetes Care Devices Indicators Comparison.
Data segmentations: Country and regional historic and forecast data, market share of
competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end
notes.
Scope

3. Diabetes Care Devices Market
Characteristics
The diabetes care devices industry manufactures blood glucose monitoring
devices and insulin delivery devices. Diabetes care devices are designed to
diagnose, monitor or manage type I and type II diabetes mellitus. Diabetes is a
chronic disease that occurs either when the pancreas does not produce enough
insulin or when the body cannot effectively use the insulin it produces. Insulin is a
hormone that regulates blood sugar. The diabetes care devices market in this
report is segmented into blood glucose test strips, insulin pens, insulin syringes,
insulin pumps and injectors, lancing devices, continuous glucose monitoring
devices and blood glucose meters.
Blood glucose test strips are used to
Insulin pens are reusable pen like tools used to
Insulin Syringes are the reusable devices used to
Insulin Pumps and Injectors are the devices with which insulin can be
Lancing Devices are used to prick the skin to
Continuous Glucose Monitoring Devices are devices which are
Blood Glucose Meters are the devices which are
In this report market value is defined as the revenues organizations earn by selling
their goods and services within the specified market, based on the price at which
they sell. Only goods and services traded between entities are included. The
revenues for a specified geography are consumption values – that is, they are
revenues generated by organizations in the specified geography within the
specified market, irrespective of where they are produced.

4. Diabetes Care Devices Market
Historic Growth
The global diabetes care devices market grew from $X billion in 2013 to $X billion
in 2017 at a compound annual growth rate (CAGR) of X%.
The chart and table below shows the year-on-year growth of the global diabetes
care devices market during 2013 – 2017.
Drivers of the Market:
Restraints on the Market:

5. Diabetes Care Devices Market
Forecast Growth
The global diabetes care devices market is expected to grow from $XX billion in
2017 to $16 billion in 2021 at a compound annual growth rate (CAGR) of XX%.
The chart and table below shows the year-on-year growth of the global diabetes
care devices market during 2017 - 2021.
Drivers of the Market:
Restraints on the Market:

6. Diabetes Care Devices Market
Segmentation
The chart and table below shows the split of the diabetes care devices market in
2017.
The total market value for diabetes care devices was $X billion in 2017. The markets
that are covered include Blood Glucose Test Strips; Insulin Pens; Insulin Syringes;
Insulin Pumps and injectors; Lancing Devices; Continuous Glucose Monitoring
Devices; Blood Glucose Meters.
Blood Glucose Test Strips was the X largest segment in the diabetes care devices
market with X% share of the market. The market value for the blood glucose test
strips was $X billion in 2017.
Insulin Pens made up around X% share of the market. The market value for the
insulin pens was $X billion in 2017.

7. Diabetes Care Devices Market
Regional And Country Analysis
The Asia Pacific was the largest region in the diabetes care devices market in 2017,
diabetes care devices for $X billion or X% market share.
North America was the x largest region diabetes care devices for $X billion or X%
market share.
Western Europe was the x largest region diabetes care devices for $X billion or X%
market share.

8. Diabetes Care Devices Market
Competitive Landscape
The leading competitors in the global diabetes care devices market are Roche,
Medtronic, J&J, Abbott, Becton, Dickinson and Company.
The chart and table below displays the percentage market share of the top players
in the diabetes care devices market industry.
Roche generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.
Medtronic generated revenues of $XX billion for the financial year 2016, an XX%
increase from the previous year.
J&J generated revenues of $XX billion for the financial year 2016, an XX%
decrease from the previous year.
Abbott generated revenues of $XX billion for the financial year 2016, an XX%
increase from the previous year.

9. Becton, Dickinson and Company generated revenues of $XX billion for the
financial year 2016, an XX% increase from the previous year.
Company Profile
Roche
Overview
Roche was the largest company in the global diabetes care devices market
with XX% market share in 2017. Roche was founded in 1896 and is
headquartered in Switzerland. It had about 88,000 employees working
across more than 150 countries.
Products and Services
Roche classifies its businesses into two reportable divisions –
The Pharmaceuticals division of the company focuses on
The Diagnostics division of the company caters to
Strategy
Roche’s key strategy is to serve patients across the healthcare spectrum,
with emphasis on clinical chemistry, tissue diagnostics, and molecular
diagnostics. The company invests approximately CHF 9 billion in research and
development every year,
Financial Performance
Roche generated revenue of CHF XX billion ($XX billion) in the financial
year 2016. The company had a market
Medtronic
Overview
Products and Services
Strategy
Financial Performance

10. J&J
Overview
Products and Services
Strategy
Financial Performance
Abbott
Overview
Products and Services
Strategy
Financial Performance
Becton, Dickinson and Company
Overview
Products and Services
Strategy
Financial Performance